Polyphosphazene microspheres for insulin delivery

被引:46
作者
Caliceti, P
Veronese, FM
Lora, S
机构
[1] Univ Padua, Dept Pharmaceut Sci, I-35131 Padua, Italy
[2] CNR, Inst Photochem & High Energy Radiat, F-35020 Padua, Italy
关键词
polyphosphazenes; microspheres; insulin; drug delivery;
D O I
10.1016/S0378-5173(00)00588-3
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Polyphosphazene based microspheres for insulin delivery were prepared following three different procedures: (A) suspension-solvent evaporation; (B) double emulsion-solvent evaporation; (C) suspension/double emulsion-solvent evaporation. Methods A and C allowed for higher protein loading than procedure B. Scanning electron microscopy showed that all preparation procedures achieve microparticles with spherical shape, porous surface and internal honeycomb structure. in all cases insulin was released 'in vitro' by a bi-modal behaviour: fast release during the first 2 hours followed by a slow release. However, both the physical properties and the 'in vitro' release profiles were found to depend upon the preparation conditions. Subcutaneous administration to diabetic mice of microspheres obtained with methods A and C rapidly reduced the glucose levels of about 80% but most of activity was lost in 100 hours. Both preparations B induced a remarkable decrease in glucose levels and the activity was maintained throughout 1000 h. Finally all preparations stimulated anti-insulin antibody production that constantly increased over a period of 8 weeks. (C) 2000 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:57 / 65
页数:9
相关论文
共 20 条
[1]   Recent developments with an impact on the future of polyphosphazene science and technology [J].
Allcock, HR .
PHOSPHORUS SULFUR AND SILICON AND THE RELATED ELEMENTS, 1999, 144 :61-64
[2]  
Allcock HR, 1990, BIODEGRADABLE POLYM, P163
[3]   Polymeric carriers for oral uptake of microparticulates [J].
Andrianov, AK ;
Payne, LG .
ADVANCED DRUG DELIVERY REVIEWS, 1998, 34 (2-3) :155-170
[4]   Protein release from polyphosphazene matrices [J].
Andrianov, AK ;
Payne, LG .
ADVANCED DRUG DELIVERY REVIEWS, 1998, 31 (03) :185-196
[5]  
CALICETI P, 1994, FARMACO, V49, P69
[6]  
Caliceti P, 1997, FARMACO, V52, P697
[7]  
CALICETI P, 1993, ORG MASS SPECTROM, V27, P153
[8]  
Chetty DJ, 1998, CRIT REV THER DRUG, V15, P629
[9]   Anti-inflammatory activity of polyphosphazene-based naproxen slow-release systems [J].
Conforti, A ;
Bertani, S ;
Lussignoli, S ;
Grigolini, L ;
Terzi, M ;
Lora, S ;
Caliceti, P ;
Marsilio, F ;
Veronese, FM .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1996, 48 (05) :468-473
[10]   BIODEGRADABLE POLYMERS .2. DEGRADATION CHARACTERISTICS OF HYDROLYSIS-SENSITIVE POLY[(ORGANO)PHOSPHAZENES] [J].
CROMMEN, JHL ;
SCHACHT, EH ;
MENSE, EHG .
BIOMATERIALS, 1992, 13 (09) :601-611